1. Attiq A, Afzal S, Ahmad W, Kandeel M. Hegemony of inflammation in atherosclerosis and coronary artery disease. Eur J Pharmacol 2024; 966: 176338.
2.
Meng PN, Nong JC, Xu Y, You W, Xu T, Wu XQ, Wu ZM, Tao BL, Guo YJ, Yin DL, Jia HB, Song Yang S, Ye F. Morphologies and composition changes in nonculprit subclinical atherosclerosis in diabetic versus nondiabetic patients with acute coronary syndrome who underwent long-term statin therapy. Sci Rep 2023; 13: 5338.
3.
Frąk W, Wojtasińska A, Lisińska W, Młynarska E, Franczyk B, Rysz J. Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease. Biomedicines 2022; 10: 1938.
4.
Hasan HR, Al-Fatlawi ACY, Al-Obaidy QM. Evaluation of the levels of kidney injury molecule-1 and cystatin C as early biomarkers for prediction of acute kidney injury complications in paediatric male patients–a case-control study. Pediatr Pol J Paediatr 2025; 100(1): 38-51.
5.
Mszar R, Katz ME, Grandhi GR, Osei AD, Gallo A, Blaha MJ. Subclinical atherosclerosis to guide treatment in dyslipidemia and diabetes mellitus. Curr Atheroscler Rep 2024; 26: 217-230.
6.
Zubirán R, Neufeld EB, Dasseux A, Remaley AT, Sorokin AV. Recent advances in targeted management of inflammation in atherosclerosis: a narrative review. Cardiol Ther 2024; 13: 465-491.
7.
Cai X, Zhang Y, Li M, Wu JH, Mai L, Li J, Yang Y, Hu Y, Huang Y. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ 2020; 370: m2297.
8.
Burleson J, Stephens DE, Rimal RN. Adherence definitions, measurement modalities, and psychometric properties in hiv, diabetes, and nutritional supplementation studies: a scoping review. Patient Prefer Adherence 2025; 19: 319-344.
9.
Kareem SA, Raoof A, Ansari A, Mylabathula P, Kumar SN, Ahmed A. Assessment of symptoms and complications in treatment of naive newly diagnosed type 2 diabetes mellitus and their correlation with glycemic parameters. Int J Health Sci 2022; 6 (S7): 3430-3438.
10.
Al-Fatlawi ACY. Association of EBV with Hodgkin and non-Hodgkin lymphoma for females and males patients: histological, molecular and survey study in Karbala, Iraq. Int J Pharm Res 2020; 12: https://doi.org/10.31838/ijpr/2020.12.01.327.
11.
Xu H, Chen X, Peng Jie, Tang X, Shui X, Yan J, Xu J, Yao B, Deng H, Yang X. 468-P: Association between sudomotor function and coronary atherosclerosis in patients with type 2 diabetes. Diabetes 2024; 73 (Suppl 1): 468-P.
12.
Yao Z, Zhang X, Deng L, Zhang J, Wen Y, Zheng D, Liu L. Exploring the genetic relationship between type 2 diabetes and cardiovascular disease: a large-scale genetic association and polygenic risk score study. Biomolecules 2024; 14: 1467.
13.
Al-Fatlawi ACY. An evaluation of blood glucose and lipid profile in female hypothyroidism patients in Kerbala province, Iraq. Biomedicine 2022; 42: 556-560.
14.
Hasan HR, Yousif Al-Fatlawi AC, Al-Obaidy QM. Kidney injury molecule-1 (KIM-1), neutrophil gelatinaseassociated lipocalin (NGAL), and CRP: a potential biomarker for early prediction of acute kidney injury (AKI) in pediatric male patients. Fam Med Prim Care Rev 2024; 26: 464-470.
15.
da Silva CN, Miot HA, Grassi TF, Dias-Melício LA, Santos L, Espósito ACC. Expression of endothelin-1, endothelin receptor-A, and endothelin receptor-B in facial melasma compared to adjacent skin. Clin Cosmet Investig Dermatol 2023; 16: 2847-2853.
16.
Jankowich M, Choudhary G. Endothelin-1 levels and cardiovascular events. Trends Cardiovasc Med 2020; 30: 1-8.
17.
Kleinert H, Forstermann U. Nitric Oxide Synthase (s). 2007;
18.
Suri A, Singh R, Tyagi S, Bhattacharjee J. The role of endothelin-1 and nitric oxide affecting endothelial dysfunction in the etiopathogenesis of ischaemic heart disease. Int J Clin Biochem Res 2023; 5: 537-540.
19.
Wang XF, Ye ZX, Chen JY, He SJ, Chang J, Yang MW, Hong FF, Wang YF, Yang SL. Roles of nitric oxide signaling pathway in atherosclerosis. Atheroscler Open Access 2018; 3: 120.
20.
Xiong YJ, Meng XD, Xu HZ, Zhu XY. Association of frailty index with all-cause and cardiovascular mortality with different diabetic status: NHANES 1999–2018. Acta Diabetol 2025; 62: 215-226.
21.
Costa Filho FF, Chaves ÁJ, Ligabó LT, Santos EM Dos, Silva DT da, Puzzi MA, Braga SL, Abizaid A, Sousa AGMR. Efficacy of patient selection for diagnostic coronary angiography in suspected coronary artery disease. Arq Bras Cardiol 2015; 105: 466-471.
22.
Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, Rizka A, Tarigan T, Harbuwono D, Purnamasari D, Soewondo P. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and tryglyceride/glucose index. Diabetes Metab Syndr Clin Res Rev 2022; 16: 102581.
23.
Al-Fatlawi ACY. Evaluation of the effects of mobile phone electromagnetic radiation on some physiological parameters and histological structure in some laboratory male mice organs. Revis Bionatura 2022; 7: 56.
24.
Scott DA, Ponir C, Shapiro MD, Chevli PA. Associations between insulin resistance indices and subclinical atherosclerosis: a contemporary review. Am J Prev Cardiol 2024; 18: 100676.
25.
Wongwananuruk T, Prasongvej P, Chantrapanichkul P, Indhavivadhana S, Tanmahasamut P, Rattanachaiyanont M, Techatraisak K, Angsuwathana S. Measures of serum markers HbA1c, HOMA-IR, HOMA-, QUICKI and G/I ratio as predictors of abnormal glucose tolerance among thai women with polycystic ovary syndrome. J Clin Med 2025; 14: 1452.
26.
Li L, Zhong H, Shao Y, Hua Y, Zhou X, Luo D. Association between the homeostasis model assessment of insulin resistance and coronary artery calcification: a meta-analysis of observational studies. Front Endocrinol (Lausanne) 2023; 14: 1271857.
27.
Blaha MJ, DeFilippis AP, Rivera JJ, Budoff MJ, Blankstein R, Agatston A, Szklo M, Lakoski SG, Bertoni AG, Kronmal RA, Blumenthal RS, Nasir K. The relationship between insulin resistance and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2011; 34: 749-751.
28.
Al-Fatlawi ACY, AlSafi WG. Hematological study of some blood parameters for B-thalassemia major patients and effect on their fertility. AIP Conference Proceedings. AIP Publishing 2020.
29.
Rosenson RS, Brewer HB, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, Kontush A, Tall AR, Webb NR. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol 2016; 13: 48-60.
30.
Ahmadi A, Argulian E, Leipsic J, Newby DE, Narula J. From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review. J Am Coll Cardiol 2019; 74: 1608-1617.
31.
Al-Fatlawi ACY. Evaluation of leptin serum concentration in cases of blood transfusion dependent Beta thalassemia and its relationship with thyroid dysfunction. Biomedicine 2022; 42: 1029-1033.
32.
Haryono A, Ramadhiani R, Ryanto GRT, Emoto N. Endothelin and the cardiovascular system: the long journey and where we are going. Biology (Basel) 2022; 11: 759.
33.
Yan P, Jimenez ER, Li Z, Bui T, Seehawer M, Nishida J, Foidart P, Stevens LE, Xie Y, Munoz Gomez M, Park SY, Long HW, Polyak K. Midkine as a driver of age-related changes and increase in mammary tumorigenesis. Cancer Cell 2024; 42: 1936-1954.
34.
Lin CH, Pan JY, Chang JJ, Chen HH, Cheng PW, Tseng CJ. Involvement of endothelial nitric oxide synthase activation in midkine-mediated central hypotensive effects. Chin J Physiol 2017; 60: 353-362.
35.
Al-Fatlawi ACY, AA ANAA, Kehiosh HJ. Histopathological and molecular studies for an association between breast cancer and epstein-barr virus in Iraqi population. Public Health 2020; 23 (S6): 679.
36.
Maruhashi T, Kihara Y, Higashi Y. Assessment of endothelium-independent vasodilation: from methodology to clinical perspectives. J Hypertens 2018; 36: 1460-14–7.
